Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 14Breast Neoplasms 12Multiple Myeloma 8Neoplasm Metastasis 5Pain 4Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Renal Insufficiency 1Pleural Effusion, Malignant 1Osteoporosis 1Osteonecrosis 1Osteolysis 1Neoplastic Cells, Circulating 1Lung Neoplasms 1Lung Metastases 1Carcinoma, Renal Cell 1Bone Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Ibandronic Acid 2pegylated granulocyte colony-stimulating factor 1Zoledronic Acid 1Pregabalin 1Kyphoplasty 1Enoxaparin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Bone Neoplasms × Zoledronic Acid × Clear all
NCT00434447 2017-02-27

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Novartis

Phase 4 Completed
73 enrolled
BreastGenitourinaryPlasma cellSarcoma

Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Prostatic Neoplasms, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡